InsiderClue
Insiders · Profile

McMinn Rachel

Chief Executive Officer at Neurogene. Filing since 22 Nov 2024. CIK 0001606302

Company
Date
Role
Action
Shares
Amount
Of holding
NGNE Neurogene Inc.
26 Mar 2026
Chief Executive Officer
Sold on a plan
3,352
$74.00K
0.2%
NGNE Neurogene Inc.
22 Nov 2024
Chief Executive Officer
Bought
47,500
$969.00K
3.8%
2 decisions on file.